Andreas Stang, MD
Adjunct Professor
Boston University School of Public Health
Epidemiology

MD, University of Cologne
MPH, Boston University School of Public Health



Prof. Andreas Stang MPH born in 1965, studied Medicine and finished his MD degree in 1992 at Free University of Berlin. He worked as a clinician from 1992 through 1994. Thereafter, he studied Public Health (MPH) (focus: epidemiology and biostatistics) at Boston University with Kenneth J Rothman and Charles Poole from 1995 through 1996. He was working as an epidemiologist at University of Essen from 1996 through 2004. Prof. Stang has been certified as an experienced epidemiologist by the German Society of Epidemiology (DGEPI) in 2000. From 2004 through 2014, he was professor of clinical epidemiology at University of Halle. Since 2009, he was director of the Institute of Clinical Epidemiology at University of Halle. In 2014, Prof. Stang became Professor of Epidemiology at the Medical Faculty, University of Duisburg-Essen, University Hospital of Essen and became director of the Center of Clinical Epidemiology. He is one of the editors of the European Journal of Epidemiology. Besides teaching at the Medical School, he teaches cancer epidemiology (3-day course) at the School of Public Health at University of Düsseldorf annually. Furthermore, he teaches a 10-day course of epidemiologic methods at Berlin School of Public Health. He also teaches within the MSE program at University of Mainz. Prof. Stang has more than 170 peer-reviewed contributions (Medline) as first, co-author or last author. His major research topics are cancer epidemiology especially cancer registry epidemiology, cardiovascular epidemiology, and epidemiologic methods. Since 2012, he is adjunct professor of epidemiology at the Department of Epidemiology, School of Public Health, Boston University.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Morawitz J, Bruckmann NM, Jannusch K, Dietzel F, Milosevic A, Bittner AK, Hoffmann O, Mohrmann S, Ruckhäberle E, Häberle L, Fendler WP, Herrmann K, Giesel FL, Antoch G, Umutlu L, Kowall B, Stang A, Kirchner J. Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer. Cancers (Basel). 2023 Jul 17; 15(14). PMID: 37509307; PMCID: PMC10377867; DOI: 10.3390/cancers15143646;
     
  2. Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Nabavi D, Sparenberg P, Weissenborn K, Gröschel K, Royl G, Poli S, Michalski D, Eschenfelder CC, Weimar C, Diener HC. Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study. Int J Stroke. 2023 Jul 04; 17474930231184366. PMID: 37306492
     
  3. Silbernagel G, Chen YQ, Rief M, Kleber ME, Hoffmann MM, Stojakovic T, Stang A, Sarzynski MA, Bouchard C, März W, Qian YW, Scharnagl H, Konrad RJ. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation. Eur Heart J. 2023 Jul 01; 44(25):2335-2345. PMID: 37155355
     
  4. Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Hauschild A, Schilling B, Loquai C, Berking C, Hüning S, Eckardt J, Gutzmer R, Reinhardt L, Glutsch V, Nikfarjam U, Erdmann M, Beckmann CL, Stang A, Kowall B, Galetzka W, Roesch A, Ugurel S, Zimmer L, Schadendorf D, Forschner A, Livingstone E. Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study. Eur J Cancer. 2023 Sep; 191:112957. PMID: 37487400
     
  5. Liutkus J, Kriukas A, Stragyte D, Mazeika E, Raudonis V, Galetzka W, Stang A, Valiukeviciene S. Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic Keratoses. Diagnostics (Basel). 2023 Jun 21; 13(13). PMID: 37443533; PMCID: PMC10340832; DOI: 10.3390/diagnostics13132139;
     
  6. Stang A. A historical note about the sufficient cause model with special consideration of the work of Max Verworn 1912. Ann Epidemiol. 2023 Jun 14; 85:1-2. PMID: 37321279
     
  7. Dieckmann KP, Isbarn H, Trocchi P, Kießling M, Wülfing C, Stang A. No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany. PLoS One. 2023; 18(5):e0286309. PMID: 37235599; PMCID: PMC10218754; DOI: 10.1371/journal.pone.0286309;
     
  8. Feller K, Abdel-Jalil N, Blockhaus C, Kröger K, Kowall B, Stang A. Impact of oral anticoagulation on inhospital mortality of patients with hip fracture - Analysis of nationwide hospitalization data. Injury. 2023 Jul; 54(7):110829. PMID: 37246114
     
  9. Kowall B, Stang A. Estimates of excess mortality during the COVID-19 pandemic strongly depend on subjective methodological choices. Herz. 2023 Jun; 48(3):180-183. PMID: 37142834; PMCID: PMC10158684; DOI: 10.1007/s00059-023-05166-6;
     
  10. Kowall B, Jöckel KH, Standl F, Stang A. On the gap between objective and perceived risks of COVID-19. Herz. 2023 Jun; 48(3):239-242. PMID: 37099172; PMCID: PMC10132419; DOI: 10.1007/s00059-023-05184-4;
     
Showing 10 of 343 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 342 publications over 22 distinct years, with a maximum of 30 publications in 2021

YearPublications
20025
20037
20049
20059
200614
200715
200818
200913
201015
201115
201210
201320
201420
201511
201616
201714
201814
201918
202027
202130
202227
202315
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

cancer epidemiology
cardiovascular epidemiology
epidemiologic methods
Contact for Mentoring:

715 Albany Street
Boston MA 02118
Google Map


Stang's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department